Purplish or brownish red discoloration of the skin associated with increase in circulating polyclonal globulins, usually GAMMA-GLOBULINS. This syndrome often occurs on the legs of women aged 20 to 40 years.
A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.
Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS).
Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.
An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE.
A severe, rapidly fatal reaction occurring most commonly in children following an infectious illness. It is characterized by large, rapidly spreading skin hemorrhages, fever, or shock. Purpura fulminans often accompanies or is triggered by DISSEMINATED INTRAVASCULAR COAGULATION.
Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.
Surgical procedure involving either partial or entire removal of the spleen.
The number of PLATELETS per unit volume in a sample of venous BLOOD.

Hypergammaglobulinemic purpura of Waldenstrom. (1/5)

We report a case of a 33-year-old-woman with a one-year history of bilateral lower extremity vasculitis and laboratory evidence of hypergammaglobulinemia with otherwise unremarkable routine laboratory and rheumatologic studies. Her clinical picture, together with histopathologic evidence of leukocytoclastic vasculitis, favor a diagnosis of hypergammaglobulinemic purpura of Waldenstrom.  (+info)

Hypergammaglobulinemic purpura in patients with Sjogren's syndrome: a report of nine cases and a review of the Japanese literature. (2/5)

Nine patients with hypergammaglobulinemic purpura associated with primary Sjogren's syndrome were presented. All patients were female (mean age 45.6) and showed recurrent purpura on the lower extremities and typical findings of Sjogren's syndrome with high gammaglobulin and IgG levels, rheumatoid factors, anti-SSA/SSB antibodies (5/5) and anti-nuclear antibodies (6/9). Vasculitis was seen in 6 patients, 4 were of the mononuclear cell type and 2 of the neutrophilic cell type. Six patients had intermediate complexes between 7S and 19S shown by serum ultracentrifugation. Immunofluorescent staining showed immunoglobulin deposition along the blood vessel walls of the skin in these patients. These data suggest that hypergammaglobulinemic purpura in Sjogren's syndrome is vasculitis caused by immunologic processes.  (+info)

Hyperglobulinaemic renal tubular acidosis: a report of nine cases. (3/5)

Of nine women with hyperglobulinaemic renal tubular acidosis four presented with acidosis and five had the "incomplete" form of the disorder. Seven patients had nephrogenic diabetes insipidus, but none had the Fanconi syndrome. Investigation showed abnormal immunoglobulins and autoantibodies in all nine patients. Diseases coexisting with renal tubular acidosis were Sjogren's syndrome, hyperglobulinaemic purpura, autoimmune liver and thyroid disease, diffuse pulmonary fibrosis, and a peripheral neuropathy. It is suggested that this type of renal tubular acidosis might be due to an autoimmune process.  (+info)

IgA and temperature dependent IgG complex formation in a patient with Waldenstrom's hypergammaglobulinaemic purpura. (4/5)

We describe a patient with hypergammaglobulinaemic purpura and show that the serum contains IgG and IgA immune complexes sedimenting between IgM and IgG on ultracentrifugation. The complexes containing IgG were markedly temperature dependent. A drop in temperature from 37 degrees C to 28 degrees C gave a seventeen-fold increase in the quantity of these complexes. This temperature dependency may be an important factor in localizing the major pathological manifestation of this disease to the skin.  (+info)

Purpura associated with hypergammaglobulinemia, renal tubular acidosis and osteomalacia. (5/5)

Two patients with hyperglobulinemia associated with purpura were studied. One had features of Sjogren's syndrome, while the other appeared to have a primary condition -- "chronic benign purpura". Both patients also had renal tubular acidosis, osteomalacia and renal calculi, with disturbed calcium metabolism and acid-base balance. Autoantibodies were detected in the serum of both patients, and mononuclear cell infiltrates were noted in skin and kidney biopsies from both.  (+info)

Hyperglobulinemic purpura is a medical condition characterized by the presence of purple-colored spots on the skin (purpura) due to bleeding under the skin caused by an abnormal increase in certain types of proteins called globulins in the blood. This condition is often associated with various underlying diseases, such as autoimmune disorders, infections, or cancer, that can lead to excessive production of these proteins.

The increased levels of globulins can cause damage to the walls of small blood vessels (capillaries), leading to leakage of red blood cells and plasma into the surrounding tissues. This results in the characteristic purpuric lesions on the skin, which may vary in size and distribution. In addition to skin manifestations, hyperglobulinemic purpura can also affect other organs, such as the kidneys, leading to further complications.

It is important to note that hyperglobulinemic purpura is a relatively rare condition, and its diagnosis typically requires a thorough evaluation of the patient's medical history, physical examination, laboratory tests, and imaging studies to identify the underlying cause and determine appropriate treatment.

Henoch-Schönlein purpura (HSP) is a type of small vessel vasculitis, which is a condition characterized by inflammation of the blood vessels. HSP primarily affects children, but it can occur in adults as well. It is named after two German physicians, Eduard Heinrich Henoch and Johann Schönlein, who first described the condition in the mid-19th century.

The main feature of HSP is a purpuric rash, which is a type of rash that appears as small, red or purple spots on the skin. The rash is caused by leakage of blood from the small blood vessels (capillaries) beneath the skin. In HSP, this rash typically occurs on the legs and buttocks, but it can also affect other parts of the body, such as the arms, face, and trunk.

In addition to the purpuric rash, HSP is often accompanied by other symptoms, such as joint pain and swelling, abdominal pain, nausea, vomiting, and diarrhea. In severe cases, it can also affect the kidneys, leading to hematuria (blood in the urine) and proteinuria (protein in the urine).

The exact cause of HSP is not known, but it is thought to be related to an abnormal immune response to certain triggers, such as infections or medications. Treatment typically involves supportive care, such as pain relief and fluid replacement, as well as medications to reduce inflammation and suppress the immune system. In most cases, HSP resolves on its own within a few weeks or months, but it can lead to serious complications in some individuals.

Purpura is a medical term that refers to the appearance of purple-colored spots on the skin or mucous membranes, caused by bleeding underneath the skin due to various factors such as blood clotting disorders, vasculitis (inflammation of the blood vessels), severe thrombocytopenia (low platelet count), or use of certain medications. These spots can vary in size and shape, ranging from small pinpoint hemorrhages (petechiae) to larger, irregularly shaped patches (ecchymoses). The bleeding is usually not caused by trauma or injury to the area. It's important to consult a healthcare professional if you notice any unexplained purpuric spots on your skin or mucous membranes, as they can indicate an underlying medical condition that requires further evaluation and treatment.

Idiopathic Thrombocytopenic Purpura (ITP) is a medical condition characterized by a low platelet count (thrombocytopenia) in the blood without an identifiable cause. Platelets are small blood cells that help your body form clots to stop bleeding. When you don't have enough platelets, you may bleed excessively or spontaneously, causing purpura, which refers to purple-colored spots on the skin that result from bleeding under the skin.

In ITP, the immune system mistakenly attacks and destroys platelets, leading to their decreased levels in the blood. This condition can occur at any age but is more common in children following a viral infection, and in adults after the age of 30-40 years. Symptoms may include easy or excessive bruising, prolonged bleeding from cuts, spontaneous bleeding from the gums or nose, blood blisters, and small red or purple spots on the skin (petechiae).

Depending on the severity of thrombocytopenia and the presence of bleeding symptoms, ITP treatment may include observation, corticosteroids, intravenous immunoglobulin (IVIG), or other medications that modify the immune system's response. In severe cases or when other treatments are ineffective, surgical removal of the spleen (splenectomy) might be considered.

Thrombotic thrombocytopenic purpura (TTP) is a rare but serious blood disorder. It's characterized by the formation of small blood clots throughout the body, which can lead to serious complications such as low platelet count (thrombocytopenia), hemolytic anemia, neurological symptoms, and kidney damage.

The term "purpura" refers to the purple-colored spots on the skin that result from bleeding under the skin. In TTP, these spots are caused by the rupture of red blood cells that have been damaged by the abnormal clotting process.

TTP is often caused by a deficiency or inhibitor of ADAMTS13, a protein in the blood that helps to regulate the formation of blood clots. This deficiency or inhibitor can lead to the formation of large clots called microthrombi, which can block small blood vessels throughout the body and cause tissue damage.

TTP is a medical emergency that requires prompt treatment with plasma exchange therapy, which involves removing and replacing the patient's plasma to restore normal levels of ADAMTS13 and prevent further clotting. Other treatments may include corticosteroids, immunosuppressive drugs, and rituximab.

Purpura fulminans is a severe, life-threatening condition characterized by the rapid progression of hemorrhagic purpura (discoloration of the skin due to bleeding under the skin) and disseminated intravascular coagulation (DIC), leading to thrombosis and necrosis of the skin and underlying tissues. It can be classified into two types: acute infectious purpura fulminans, which is caused by bacterial infections such as meningococcus or pneumococcus; and chronic purpura fulminans, which is associated with autoimmune disorders or protein C or S deficiencies. The condition can lead to serious complications such as sepsis, organ failure, and death if not promptly diagnosed and treated.

Plasma exchange, also known as plasmapheresis, is a medical procedure where the liquid portion of the blood (plasma) is separated from the blood cells. The plasma, which may contain harmful substances such as antibodies, clotting factors, or toxins, is then removed and replaced with fresh plasma or a plasma substitute. This process helps to remove the harmful substances from the blood and allows the body to replenish its own plasma with normal components. Plasma exchange is used in the treatment of various medical conditions including autoimmune diseases, poisonings, and certain types of kidney diseases.

A splenectomy is a surgical procedure in which the spleen is removed from the body. The spleen is an organ located in the upper left quadrant of the abdomen, near the stomach and behind the ribs. It plays several important roles in the body, including fighting certain types of infections, removing old or damaged red blood cells from the circulation, and storing platelets and white blood cells.

There are several reasons why a splenectomy may be necessary, including:

* Trauma to the spleen that cannot be repaired
* Certain types of cancer, such as Hodgkin's lymphoma or non-Hodgkin's lymphoma
* Sickle cell disease, which can cause the spleen to enlarge and become damaged
* A ruptured spleen, which can be life-threatening if not treated promptly
* Certain blood disorders, such as idiopathic thrombocytopenic purpura (ITP) or hemolytic anemia

A splenectomy is typically performed under general anesthesia and may be done using open surgery or laparoscopically. After the spleen is removed, the incision(s) are closed with sutures or staples. Recovery time varies depending on the individual and the type of surgery performed, but most people are able to return to their normal activities within a few weeks.

It's important to note that following a splenectomy, individuals may be at increased risk for certain types of infections, so it's recommended that they receive vaccinations to help protect against these infections. They should also seek medical attention promptly if they develop fever, chills, or other signs of infection.

A platelet count is a laboratory test that measures the number of platelets, also known as thrombocytes, in a sample of blood. Platelets are small, colorless cell fragments that circulate in the blood and play a crucial role in blood clotting. They help to stop bleeding by sticking together to form a plug at the site of an injured blood vessel.

A normal platelet count ranges from 150,000 to 450,000 platelets per microliter (µL) of blood. A lower than normal platelet count is called thrombocytopenia, while a higher than normal platelet count is known as thrombocytosis.

Abnormal platelet counts can be a sign of various medical conditions, including bleeding disorders, infections, certain medications, and some types of cancer. It is important to consult with a healthcare provider if you have any concerns about your platelet count or if you experience symptoms such as easy bruising, prolonged bleeding, or excessive menstrual flow.

Waldenström hyperglobulinemic purpura is a skin condition that presents with episodic showers of petechiae (small red or purple ...
Hyperglobulinemic purpura caused by increased gamma-globulin levels has a presentation similar to those of the disorders ... What is the role of hyperglobulinemic purpura in the etiology of nonplatelet hemostatic disorders? ... Thrombotic thrombocytopenic purpura. Thrombotic thrombocytopenic purpura (TTP) is a clinical syndrome classically characterized ... Henoch-Schonlein purpura: a review of the literature. Clin Excell Nurse Pract. 2000 Mar. 4(2):72-5. [QxMD MEDLINE Link]. ...
Mycophenolate mofetil treatment of a patient with hyperglobulinemic purpura. J Am Acad Dermatol 2004;51:667-9. ... Hypergammaglobulinemic purpura of Waldenström is a rare syndrome characterized by recurrent episodes of purpura occurring ... thrombocytopenic purpura, Henoch-Schonlein purpura, pigmentary purpuric dermatosis, monoclonal gammopathy, and lymphoma. ... As we know, purpura is one of the clinicopathologic entities which presents as the initial manifestation of a variety of ...
PURPURA] 89. ԾՆՈՏՆԵՐԻ ԱՆԿԱՆՈՆՈՒԹՅՈՒՆՆԵՐ [JAW ABNORMALITIES] 40. ԾԻՐԱՆԱՑԱՆ ԳԵՐԳԼՈԲՈՒԼԱՐՅՈՒՆԱՅԻՆ [PURPURA, HYPERGLOBULINEMIC] 90. ... PURPURA, THROMBOCYTOPENIC] 92. ԾՆՈՏՆԵՐԻ ՀԻՎԱՆԴՈՒԹՅՈՒՆՆԵՐ [JAW DISEASES] 43. ԾԻՐԱՆԱՑԱՆ ՇԵՆԼԵՅՆ-ՀԵՆՈԽԻ [PURPURA, SCHOENLEIN- ... PURPURA, THROMBOTIC THROMBOCYTOPENIC] 91. ԾՆՈՏՆԵՐԻ ՀԱՐԱԲԵՐԱԿՑՈՒԹՅԱՆ(ՉԱՓԵՐԻ) ՈՐՈՇՈՒՄԸ [JAW RELATION RECORD] 42. ԾԻՐԱՆԱՑԱՆ ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic [C14.907.454.550] * Scurvy [C14.907.454.800] * Shwartzman Phenomenon [C14.907.454.810] * ...
Purpura, Hyperglobulinemic. *Scurvy. *Shwartzman Phenomenon. *Telangiectasia, Hereditary Hemorrhagic. *Waldenstrom ...
Purpura, Hyperglobulinemic. *Purpura, Schoenlein-Henoch. *Scurvy. *Shwartzman Phenomenon. *Telangiectasia, Hereditary ...
Purpura, Hyperglobulinemic [C15.378.463.515.550] Purpura, Hyperglobulinemic * IgA Vasculitis [C15.378.463.515.580] ...
Hyperglobulinemic purpura ‎ (← links). *Marinescu-Garland syndrome ‎ (← links). *Spondylodiscitis ‎ (← links). *Jaffe- ...
Hyperglobulinemic purpura ‎ (← links). *Marinescu-Garland syndrome ‎ (← links). *Spondylodiscitis ‎ (← links). *Jaffe- ...
Hyperglobulinemic Purpura of Waldenström * Cryofibrinogenemia * Primary Cutaneous Diseases * DISORDERS SIMULATING PURPURA * ... The female easy-bruising syndrome (purpura simplex) is purpura or ecchymoses occurring predominantly in women, frequently on ... NONPALPABLE PURPURA * Increased Transmural Pressure Gradient * Decreased Mechanical Integrity of the Microvasculature or ... Actinic (senile) purpura is red to purple irregular patches on the extensor surfaces of the forearm and hands. ...
Waldenstrom Hyperglobulinemic Purpura use Purpura, Hyperglobulinemic Waldenström Hyperglobulinemic Purpura use Purpura, ... Waldenstrom Hypergammaglobulinemic Purpura use Purpura, Hyperglobulinemic ...
Keywords Vasculitis, ulcer, small-vessel vasculitis, cutaneous vasculitis, purpura, leg ulcer. ISSN 1941-6806. doi: 10.3827/ ... patients with hyperglobulinemic states and cryoglobulinemia may have small-vessel vasculitis and, occasionally, it is ... The first historical accounts of vasculitis are of small-vessel vasculitis, especially forms associated with purpura [1]. The ... Figure 3 Palpable purpura with several non-blanchable, pinpoint, erythematous lesions of the bilateral upper and lower ...
Hyperglobulinemic purpura caused by increased gamma-globulin levels has a presentation similar to those of the disorders ... What is the role of hyperglobulinemic purpura in the etiology of nonplatelet hemostatic disorders? ... Thrombotic thrombocytopenic purpura. Thrombotic thrombocytopenic purpura (TTP) is a clinical syndrome classically characterized ... Henoch-Schonlein purpura: a review of the literature. Clin Excell Nurse Pract. 2000 Mar. 4(2):72-5. [QxMD MEDLINE Link]. ...
Purpura, Hyperglobulinemic -- WH 320 *Rainforest -- QH 541.5.R27 *Range of Motion, Articular -- WE 141 ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
... requires 4 criteria for diagnosing Henoch-Schönlein purpura[2]: palpable purpura, patient age 20 years or younger at onset, ... Table 1. Etiology of Purpura Intravascular (usually nonpalpable). *. Alterations in platelet formation, destruction, or ... The sine qua non for the diagnosis of Henoch-Schönlein purpura is the staining of vessels with IgA in the context of a ... Several guidelines are available for the diagnosis of Henoch-Schönlein purpura.[1] The American College of Rheumatology (ACR) ...
Hyperglobulinemic purpura (disorder). Code System Preferred Concept Name. Hyperglobulinemic purpura (disorder). Concept Status ...
Hyperglobulinemic Purpura Hyperglobulinemic Purpura of Waldenström Hyperglobulinemic Purpura, Waldenstrom Hyperglobulinemic ... Hyperglobulinemic Purpura. Hyperglobulinemic Purpura of Waldenström. Hyperglobulinemic Purpura, Waldenstrom. Hyperglobulinemic ... Waldenstrom Hyperglobulinemic Purpura Waldenström Hyperglobulinemic Purpura Hypergammaglobulinemic Purpura of Waldenstrom - ... Waldenstrom Hypergammaglobulinemic Purpura. Waldenstrom Hyperglobulinemic Purpura. Waldenström Hyperglobulinemic Purpura. Tree ...
Hyperglobulinemic Purpura Hyperglobulinemic Purpura of Waldenström Waldenstrom Hyperglobulinemic Purpura NLM Classification #. ... Benign Hyperglobulinemic Purpura of Waldenström Hypergammaglobulinemic Purpura of Waldenstrom ... Benign Hyperglobulinemic Purpura of Waldenström Term UI T680177. Date08/24/2006. LexicalTag EPO. ThesaurusID NLM (2008). ... Purpura, Hyperglobulinemic Preferred Term Term UI T034570. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1966). ...
Hyperglobulinemic Purpura Hyperglobulinemic Purpura of Waldenström Waldenstrom Hyperglobulinemic Purpura NLM Classification #. ... Benign Hyperglobulinemic Purpura of Waldenström Hypergammaglobulinemic Purpura of Waldenstrom ... Benign Hyperglobulinemic Purpura of Waldenström Term UI T680177. Date08/24/2006. LexicalTag EPO. ThesaurusID NLM (2008). ... Purpura, Hyperglobulinemic Preferred Term Term UI T034570. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1966). ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Purpura, Hyperglobulinemic C14.907.934.550 C14.907.454.550. Purpura, Schoenlein-Henoch C14.907.934.580. Putamen A8.186.211.730. ...
Classify works on hyperglobulinemic purpura in WH 322.. WH 322 Blood coagulation disorders (General) ...
Hyperglobulinemic Purpura, Schoenlein-Henoch Purpura, Thrombocytopenic Purpura, Thrombocytopenic, Idiopathic Purpura, ... Purinones Purkinje Cells Purkinje Fibers Puromycin Puromycin Aminonucleoside Purple Membrane Purpura Purpura Fulminans Purpura ...
Purpura Fulminans. *Purpura, Hyperglobulinemic. *Purpura, Schoenlein-Henoch. *Purpura, Thrombocytopenic. *Waterhouse- ... "Purpura, Schoenlein-Henoch" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ... This graph shows the total number of publications written about "Purpura, Schoenlein-Henoch" by people in this website by year ... A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES ...
Purpura, Hyperglobulinemic. *Purpura, Schoenlein-Henoch. *Scurvy. *Shwartzman Phenomenon. *Telangiectasia, Hereditary ...
Purpura, Hyperglobulinemic. *Purpura, Schoenlein-Henoch. *Scurvy. *Shwartzman Phenomenon. *Telangiectasia, Hereditary ...
Hyperglobulinemic purpura ‎ (← links). *Marinescu-Garland syndrome ‎ (← links). *Spondylodiscitis ‎ (← links). *Jaffe- ...
Hyperglobulinemic purpura ‎ (← links). *Marinescu-Garland syndrome ‎ (← links). *Idiopathic venoocclusive disease ‎ (← links). ...
Hyperglobulinemic purpura ‎ (← links). *Marinescu-Garland syndrome ‎ (← links). *Spondylodiscitis ‎ (← links). *Jaffe- ...

No FAQ available that match "purpura hyperglobulinemic"

No images available that match "purpura hyperglobulinemic"